跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEBCIN tobramycin 80mg/2mL (as sulfate)Injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
NEBCIN tobramycin 80mg/2mL (as sulfate)Injection vial
Approved
STANDARD
NEBCIN tobramycin 80mg/2mL (as sulfate)Injection vial
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
006db210f284e02f
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
006db210f284e02f
Product Name
NEBCIN tobramycin 80mg/2mL (as sulfate)Injection vial
Artg Id
77034
Artg Name
NEBCIN tobramycin 80mg/2mL (as sulfate) Injection vial
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2001-06-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
006db210f284e02f
Type
Standard
Back to TGA Approvals
